PAVmed financials
$3.82+0.53%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33.0K | $22.0K | $52.0K | $5.0K | $6.0K | $8.0K | $10.0K | $996.0K | $979.0K | $1.0M | $1.0M | $791.0K |
| Gross profit | -$89.0K | -$75.0K | -$33.0K | -$50.0K | -$35.0K | -$28.0K | -$38.0K | -$385.0K | -$687.0K | -$734.0K | -$562.0K | -$988.0K |
| Gross margin | −269.7% | −340.9% | −63.5% | −1000.0% | −583.3% | −350.0% | −380.0% | −38.7% | −70.2% | −72.7% | −53.6% | −124.9% |
| Operating income | -$3.9M | -$8.0M | -$6.8M | -$4.8M | -$1.6M | -$5.4M | -$5.2M | -$11.6M | -$13.7M | -$14.0M | -$16.4M | -$15.5M |
| Net income | -$5.5M | -$7.0M | -$1.8M | -$6.3M | -$13.3M | $17.7M | $1.3M | $64.3M | -$10.9M | -$22.8M | -$15.9M | -$17.7M |
| Net margin | −16603.0% | −31763.6% | −3523.1% | −126560.0% | −221800.0% | 221187.5% | 13460.0% | 6457.4% | −1114.2% | −2256.2% | −1516.2% | −2243.7% |
| Diluted EPS | $-0.87 | $-4.42 | — | $-8.70 | $-22.08 | $10.10 | $0.20 | $43.20 | $-35.70 | $-78.60 | $-59.39 | $-71.40 |
| EBITDA | -$3.9M | -$8.0M | -$6.8M | -$4.9M | -$1.5M | -$5.4M | -$5.2M | -$11.5M | -$13.2M | -$13.4M | -$15.7M | -$14.8M |
| Operating cash flow | -$2.7M | -$2.6M | -$1.6M | -$896.0K | -$1.2M | -$1.6M | $94.0K | -$8.9M | -$11.7M | -$13.1M | -$11.9M | -$11.1M |
| Free cash flow | -$2.7M | -$2.6M | -$1.6M | -$899.0K | -$1.2M | -$1.6M | $90.0K | -$8.9M | -$11.7M | -$13.2M | -$12.1M | -$11.1M |
| Diluted shares | 6.3M | 1.6M | — | 0.7M | 0.6M | 1.7M | 6.6M | 1.5M | 0.3M | 0.3M | 0.3M | 0.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.8M | $6.5M | $1.5M | $3.1M | $4.0M | $2.7M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $15.1M | $14.9M | $11.1M | $6.9M | $6.8M | $6.6M |
| Total assets | $40.2M | $45.4M | $38.8M | $38.1M | $43.9M | $52.8M |
| Total liabilities | $20.9M | $20.4M | $16.5M | $12.3M | $12.5M | $11.9M |
| Shareholders' equity | $19.3M | $25.0M | $22.3M | $22.5M | $28.2M | $38.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology